Abstract
Little is known about costs and cost-effectiveness of liver transplantation (LTx) for acute liver failure compared to costs and cost-effectiveness of LTx for chronic liver failure. In this study, costs of acute and of chronic LTx patients were determined in a retrospective study. Files of 100 consecutive patients who underwent LTx in 1993–1997 were studied. Costs up to 1 year after LTx were Euro 107,675 (chronic liver failure) and Euro 90,792 (acute liver failure). The difference was mainly caused by higher hospitalisation costs and higher personnel costs for chronic liver failure. Medication costs for acute liver failure were higher, due to a high administration rate of expensive anti-HBs immunoglobulin therapy in patients with viral hepatitis B. LTx for chronic liver failure is more costly and seems to be more cost-effective than LTx for acute liver failure, since 1-year survival is higher in patients who underwent transplantation for chronic liver failure.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 25 October 1999 Revised: 29 September 2000 Accepted: 18 December 2000
About this article
Cite this article
van Agthoven, M., Metselaar, H., Tilanus, H. et al. A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure. Transpl Int 14, 87–94 (2001). https://doi.org/10.1007/s001470050852
Issue Date:
DOI: https://doi.org/10.1007/s001470050852